INTERLEUKIN-10 (IL-10) PROMOTER POLYMORPHISM AT POSITION -1082 IN BULGARIAN PATIENTS WITH MULTIPLE SCLEROSIS

被引:2
|
作者
Grigorov, Boncho G. [1 ]
Trenova, Anastasiya G. [2 ]
Slavov, Georgi S. [2 ]
Miteva, Lyuba D. [1 ]
Stanilova, Spaska A. [1 ]
机构
[1] Trakia Univ, Fac Med, Dept Mol Biol Immunol & Med Genet, 11 Armeiska St, Stara Zagora 6000, Bulgaria
[2] Med Univ Plovdiv, Fac Med, Dept Neurol, 15A,V Aprilov St, Plovdiv 4000, Bulgaria
来源
关键词
rs1800896; disease onset; RRMS; SNP; cytokine; IL10; GENE; ASSOCIATION;
D O I
10.7546/CRABS.2019.01.11
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The role of promoter polymorphism within IL10 (rs1800896) in multiple sclerosis (MS) is not well established. The aim of this study was to investigate the association between -1082A/G polymorphism in interleukin-10 and genetic predisposition to MS development and onset of disease in Bulgarian patients. A group of 159 patients with relapsing remitting MS (RRMS) and 221 age-sex-matched controls were genotyped by amplification refractory mutation system (ARMS)-PCR. Our results demonstrated statistically significant elevation of the AA-genotype frequency in RRMS cases, compared to controls (38.4% vs. 28.5% with OR = 1.561, 95% CI = 0.989 divided by 2.464, P = 0.043). In addition, AA-genotype was overrepresented in cases with late-onset of disease than controls (44% vs. 28.5% with OR = 1.971, 95% CI = 1.107 divided by 3.508, P = 0.013). We also found that the carrying of AG-genotype was associated with a 1.8 fold increase of risk for early-onset of RRMS. In conclusion, our present results indicate that AA-genotype of -1082 G/A SNP in IL10 (rs1800896) might be accepted as a risk factor for RRMS susceptibility in Bulgarian patients and could be associated with manifestation of disease after the age of 30 years.
引用
收藏
页码:84 / 91
页数:8
相关论文
共 50 条
  • [1] Interleukin-10 (IL-10) 1082 promoter polymorphisms and plasma IL-10 levels in patients with bacterial sepsis
    Vivas, Monica Chavez
    Villamarin-Guerrero, Hector Fabio
    Sanchez, Carlos Alberto
    ROMANIAN JOURNAL OF INTERNAL MEDICINE, 2021, 59 (01) : 50 - 57
  • [2] Interleukin-10 (IL10) promoter polymorphisms and multiple sclerosis
    Pickard, C
    Mann, C
    Sinnott, P
    Boggild, M
    Hawkins, C
    Strange, RC
    Hutchinson, IV
    Ollier, WER
    Donn, RP
    JOURNAL OF NEUROIMMUNOLOGY, 1999, 101 (02) : 207 - 210
  • [3] Interleukin 10 (IL-10) promoter-1082 A > G polymorphism and risk of cancer: Metaanalysis
    Khan, Muhammad Tahir
    Afzal, Sahar
    Rehman, Ashfaq Ur
    Zeb, Tariq
    ADVANCEMENTS IN LIFE SCIENCES, 2015, 2 (02): : 67 - 73
  • [4] Promoter polymorphism of IL-10 and severity of multiple sclerosis
    Luomala, M
    Lehtimäki, T
    Huhtala, H
    Ukkonen, M
    Koivula, T
    Hurme, M
    Elovaara, I
    ACTA NEUROLOGICA SCANDINAVICA, 2003, 108 (06): : 396 - 400
  • [5] Placental deficiency of interleukin-10 (IL-10) in preeclampsia and its relationship to an IL10 promoter polymorphism
    Makris, A
    Xu, B
    Yu, B
    Thornton, C
    Hennessy, A
    PLACENTA, 2006, 27 (4-5) : 445 - 451
  • [6] Interleukin-10 promoter polymorphisms in patients with multiple sclerosis
    Myhr, KM
    Vågnes, KS
    Maroy, TH
    Aarseth, JH
    Nyland, HI
    Vedeler, CA
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 202 (1-2) : 93 - 97
  • [7] Polymorphism in the interleukin-10 (IL-10) gene in patients with inflammatory bowel disease
    Aithal, PG
    Grove, J
    Daly, AK
    Han, S
    Welfare, M
    Jones, DEJ
    Day, CP
    Hudson, M
    GUT, 1998, 42 : A46 - A46
  • [8] Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression
    Almeras, L
    Meresse, B
    de Seze, J
    Lefranc, D
    Dubucquoi, S
    Fajardy, I
    Vermersch, P
    Prin, L
    EUROPEAN CYTOKINE NETWORK, 2002, 13 (02) : 200 - 206
  • [9] Interleukin-10 (IL-10) gene promoter polymorphism as a potential host susceptibility factor in Pakistani patients with pulmonary tuberculosis
    Akhtar, Hashaam
    Tahir, Sadia
    Qadri, Ishtiaq
    CYTOKINE, 2010, 52 (1-2) : 93 - 93
  • [10] Genetic variation at position-1082 of the interleukin 10 (IL10) promotor and the outcome of multiple sclerosis
    Mäurer, M
    Kruse, N
    Giess, R
    Toyka, KV
    Rieckmann, P
    JOURNAL OF NEUROIMMUNOLOGY, 2000, 104 (01) : 98 - 100